The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granoff, D. M.
Right arrow Articles by Rappuoli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granoff, D. M.
Right arrow Articles by Rappuoli, R.
The Journal of Immunology, 2001, 167: 6487-6496.
Copyright © 2001 by The American Association of Immunologists

A Novel Mimetic Antigen Eliciting Protective Antibody to Neisseria meningitidis1

Dan M. Granoff2,*, Gregory R. Moe*, Marzia M. Giuliani{dagger}, Jeannette Adu-Bobie{dagger}, Laura Santini{dagger}, Brunella Brunelli{dagger}, Francesca Piccinetti{dagger}, Patricia Zuno-Mitchell*, Sharon S. Lee*, Paolo Neri{ddagger}, Luisa Bracci{ddagger}, Luisa Lozzi{ddagger} and Rino Rappuoli{dagger}

* Children’s Hospital Oakland Research Institute, Oakland, CA 94609; {dagger} Instituto Ricerche Immunobiologiche, Chiron, Siena, Italy; and {ddagger} Department of Molecular Biology, University of Siena, Siena, Italy

Molecular mimetic Ags are of considerable interest as vaccine candidates. Yet there are few examples of mimetic Ags that elicit protective Ab against a pathogen, and the functional activity of anti-mimetic Abs has not been studied in detail. As part of the Neisseria meningitidis serogroup B genome sequencing project, a large number of novel proteins were identified. Herein, we provide evidence that genome-derived Ag 33 (GNA33), a lipoprotein with homology to Escherichia coli murein transglycosylase, elicits protective Ab to meningococci as a result of mimicking an epitope on loop 4 of porin A (PorA) in strains with serosubtype P1.2. Epitope mapping of a bactericidal anti-GNA33 mAb using overlapping peptides shows that the mAb recognizes peptides from GNA33 and PorA that share a QTP sequence that is necessary but not sufficient for binding. By flow cytometry, mouse antisera prepared against rGNA33 and the anti-GNA33 mAb bind as well as an anti-PorA P1.2 mAb to the surface of eight of nine N. meningitidis serogroup B strains tested with the P1.2 serosubtype. Anti-GNA33 Abs also are bactericidal for most P1.2 strains and, for susceptible strains, the activity of an anti-GNA33 mAb is similar to that of an anticapsular mAb but less active than an anti-P1.2 mAb. Anti-GNA Abs also confer passive protection against bacteremia in infant rats challenged with P1.2 strains. Thus, GNA33 represents one of the most effective immunogenic mimetics yet described. These results demonstrate that molecular mimetics have potential as meningococcal vaccine candidates.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
L. Fantappie, M. M. E. Metruccio, K. L. Seib, F. Oriente, E. Cartocci, F. Ferlicca, M. M. Giuliani, V. Scarlato, and I. Delany
The RNA Chaperone Hfq Is Involved in Stress Response and Virulence in Neisseria meningitidis and Is a Pleiotropic Regulator of Protein Expression
Infect. Immun., May 1, 2009; 77(5): 1842 - 1853.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. M. Giuliani, J. Adu-Bobie, M. Comanducci, B. Arico, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, B. Capecchi, et al.
Inaugural Article: A universal vaccine for serogroup B meningococcus
PNAS, July 18, 2006; 103(29): 10834 - 10839.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Robinson, K. G. Wooldridge, D. B. Wells, A. Hasan, I. Todd, A. Robins, R. James, and D. A. A. Ala'Aldeen
T-Cell-Stimulating Protein A Elicits Immune Responses during Meningococcal Carriage and Human Disease
Infect. Immun., August 1, 2005; 73(8): 4684 - 4693.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. M. Giuliani, L. Santini, B. Brunelli, A. Biolchi, B. Arico, F. Di Marcello, E. Cartocci, M. Comanducci, V. Masignani, L. Lozzi, et al.
The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies
Infect. Immun., February 1, 2005; 73(2): 1151 - 1160.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Adu-Bobie, P. Lupetti, B. Brunelli, D. Granoff, N. Norais, G. Ferrari, G. Grandi, R. Rappuoli, and M. Pizza
GNA33 of Neisseria meningitidis Is a Lipoprotein Required for Cell Separation, Membrane Architecture, and Virulence
Infect. Immun., April 1, 2004; 72(4): 1914 - 1919.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. D. Fletcher, L. Bernfield, V. Barniak, J. E. Farley, A. Howell, M. Knauf, P. Ooi, R. P. Smith, P. Weise, M. Wetherell, et al.
Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein
Infect. Immun., April 1, 2004; 72(4): 2088 - 2100.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
V. Masignani, M. Comanducci, M. M. Giuliani, S. Bambini, J. Adu-Bobie, B. Arico, B. Brunelli, A. Pieri, L. Santini, S. Savino, et al.
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
J. Exp. Med., March 17, 2003; 197(6): 789 - 799.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
R. Moxon and R. Rappuoli
Bacterial pathogen genomics and vaccines
Br. Med. Bull., July 1, 2002; 62(1): 45 - 58.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.